Sales decline 21.79% to Rs 280.67 crore
Net loss of Nectar Lifescience reported to Rs 63.23 crore in the quarter ended June 2025 as against net profit of Rs 2.97 crore during the previous quarter ended June 2024. Sales declined 21.79% to Rs 280.67 crore in the quarter ended June 2025 as against Rs 358.85 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales280.67358.85 -22 OPM %-22.0511.09 -PBDT-80.2420.38 PL PBT-96.754.92 PL NP-63.232.97 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
